Ringing in 2018 with an exciting rotavirus vaccine milestone

Ringing in 2018 with an exciting rotavirus vaccine milestone hrandall Tue, 01/23/2018 – 16:53 Jan 24, 2018 Allison Clifford Communications Officer for the Vaccine Development program at PATH Rotavirus vaccines are starting off the new year with a bang! Bharat Biotech just announced that ROTAVAC® has achieved prequalification by the World Health Organization (WHO), making it available for procurement by United Nations agencies and Gavi, the Vaccine Alliance, for use in low-resource countries. This marks the first new rotavirus vaccine to achieve WHO prequalification since 2009, bringing a new affordable option to the table for low-resource countries.   Rotavirus is the most common cause of severe diarrheal disease in children worldwide, and vaccines are the best way to prevent this terrible illness. Although more than 90 countries have already introduced rotavirus vaccines into their national immunization programs, 67 percent of all children—more than 90 million infants—still lack access to rotavirus vaccines

Excerpt from:  

Ringing in 2018 with an exciting rotavirus vaccine milestone